Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Published on by Academic Awards

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Assist Prof Dr Maryam Tabarzad, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iran

Based on Dr. Maryam Tabarzad’s profile, she appears to be a strong candidate for the Best Researcher Award due to several key factors:

Publication profile

google scholar

Educational Background

  • MSc in E-learning in Medical Education (2023): Focused on enhancing lab skills through augmented reality in pharmacy students.
  • PhD in Pharmaceutical Biotechnology (2014): Specialized in DNA aptamers against Coagulation Factor VIII.
  • Pharm.D. (2007): Conducted research on bis(4-nitroaryl-1,4-Dihydropyridine) with pharmacological evaluations.

Professional Experience

  • Assistant Professor: Protein Technology Research Center, Shahid Beheshti University of Medical Science (2014-present).
  • Vice-Chancellor of Research Affairs: Protein Technology Research Center (2018-present).
  • Editorial Roles: Managing Editor for Trends in Peptide and Protein Sciences, Associate Editor for Iranian Journal of Pharmaceutical Research, and Editorial member for Future Natural Products.

Notable Publications

  1. Fathi et al. (2024): Investigated antimicrobial peptides for wound healing, published in Burns (Q2, IF: 3.2).
  2. Fathi et al. (2024): Explored structural features of antimicrobial peptides in Bioorganic Chemistry (Q1, IF: 5.1).
  3. Yazdanicherati et al. (2024): Studied the effect of antimicrobial peptides on gold nanoparticles, published in Modares Journal of Biotechnology.

Teaching Experience

  • Extensive teaching roles in pharmaceutical and medical biotechnology across various institutions, including University of Science and Culture, Gilan University of Medical Sciences, and Shahid Beheshti University of Medical Sciences.

Thesis Supervision

  • Supervised multiple Ph.D. and MSc theses in areas such as biosensors, peptide-nanomolecule interactions, and cancer research.

Conclusion

Dr. Maryam Tabarzad’s impressive academic credentials, significant contributions to pharmaceutical biotechnology, influential editorial roles, and robust teaching and supervisory experience make her a highly suitable candidate for the Best Researcher Award. Her research, particularly in the design and development of antimicrobial peptides and aptamers, along with her leadership in research and education, underscores her excellence in the field.

Publication top notes

Therapeutic applications of nucleic acid aptamers in microbial infections

Aptamers as smart ligands for nano-carriers targeting

Anti-inflammatory activity of bioactive compounds from microalgae and cyanobacteria by focusing on the mechanisms of action

Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication

Silymarin antiproliferative and apoptotic effects: insights into its clinical impact in various types of cancer

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers

Anti-cancer drug delivery using carbohydrate-based polymers

Trends in the design and development of specific aptamers against peptides and proteins

Peptide dendrimers as valuable biomaterials in medical sciences

Piotr Fiedor | Medicinal products | Academic Excellence in Entrepreneurship Award

Published on by Academic Awards

Prof Dr. Piotr Fiedor | Medicinal products | Academic Excellence in Entrepreneurship Award

Prof Dr. Piotr Fiedor, Piotr Fiedor, Professor of Surgery, Warsaw Medical University, Dept. of General and Transplantation Surgery, Poland

Prof. Dr. Piotr Fiedor, MD, PhD is a distinguished surgeon and academic with extensive expertise in general surgery, oncology, transplant immunology, and medical research. Since 1995, he has served at the Department of General and Transplantation Surgery, Warsaw Medical University. 🌟 He has held pivotal roles such as CEO of the National Medicines Institute and a member of the European Medicines Agency’s CHMP. 🌍 Dr. Fiedor has been involved in over 210 scientific papers and numerous prestigious projects, contributing significantly to the fields of biotechnology and personalized medicine. 📚🏆 His accolades include Poland’s “Gold Cross of Merit” and numerous scientific awards. 🏅

 

Publication Profile

Scopus

Education 🎓

Professor Piotr Fiedor completed a prestigious fellowship in transplantation immunology and immunomodulation at the College of Physicians and Surgeons, Columbia University, USA, from 1993 to 1996. He further enhanced his medical expertise through a clinical oncology internship at the Institute-Center of Oncology between 2006 and 2008.

Teaching Experience 🎓

From 1986 to 2005, Professor Piotr Fiedor served as an Adjunct and Associate Professor of Surgery at Warsaw Medical University. His teaching focus encompassed general medicine, transplantation, and oncology, significantly contributing to the academic growth of numerous medical students.

Administrative Experience 🏥

Since 2015, Dr. Fiedor has been the Chief Executive Officer of the National Medicines Institute in Warsaw, overseeing the quality control of medicinal products. His previous administrative roles include harmonization and registration expertise at The Office for Registration of Medicinal Products (2007-2010) and leadership in clinical trials inspection at the National Institute of Health (1997-2001).

Awards and Honours 🏅

Dr. Fiedor’s accolades include the “Gold Cross of Merit” (2011) and the “Silver Cross of Merit” (2005) awarded by the President of Poland. He has also received the first-degree team teaching award (2012) for co-authoring a textbook on disaster medicine and numerous team science awards for his significant contributions to medical research and education.

 

Research Focus 🔬

Professor Piotr Fiedor’s research is predominantly focused on transplantation medicine, immunology, and oncology. His recent works include investigating the educational and therapeutic support for rare disease transplant recipients and studying long-term outcomes of surgical treatments in immunocompromised patients. He has also contributed significantly to COVID-19 research, exploring the effects of amantadine on unvaccinated patients and the analysis of pathological changes in COVID-19 imaging databases. His interdisciplinary research extends to dermatological therapies and chronic wound treatments, showcasing a commitment to improving patient outcomes across various medical fields. 🌟

Publication Top Notes